BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qin RY, Fang RL, Gupta MK, Liu ZR, Wang DY, Chang Q, Chen YB. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis. World J Gastroenterol 2004; 10(1): 132-135 [PMID: 14695784 DOI: 10.3748/wjg.v10.i1.132]
URL: https://www.wjgnet.com/1007-9327/full/v10/i1/132.htm
Number Citing Articles
1
Frank P. Leu, Minesh Nandi, Congrong Niu. The Effect of Transforming Growth Factor β on Human Neuroendocrine Tumor BON Cell Proliferation and Differentiation Is Mediated through Somatostatin SignalingMolecular Cancer Research 2008; 6(6): 1029 doi: 10.1158/1541-7786.MCR-07-2073
2
M. Kilian, J. I. Gregor, I. Heukamp, K. Helmecke, M. Hanel, B. Wassersleben, M. K. Walz, I. Schimke, G. Kristiansen, F. A. Wenger. Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian HamsterClinical & Experimental Metastasis 2009; 26(7): 719 doi: 10.1007/s10585-009-9271-x
3
Zhi-Yong Du, Ren-Yi Qin, Wei Xia, Rui Tian, Manoj Kumar. Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenograftsWorld Journal of Gastroenterology 2005; 11(4): 516-520 doi: 10.3748/wjg.v11.i4.516
4
Xiao-Ping He, Zhao-Shen Li, Ren-Min Zhu, Zhen-Xing Tu, Jun Gao, Xue Pan, Yan-Fang Gong, Jing Jin, Xiao-Hua Man, Hong-Yu Wu, Ai-Fang Xu. Effects of recombinant human canstatin protein in the treatment of pancreatic cancerWorld Journal of Gastroenterology 2006; 12(41): 6652-6657 doi: 10.3748/wjg.v12.i41.6652